{
    "Rank": 423,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT02150447",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "NCCCTS09420"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "0910090",
                            "SecondaryIdType": "Other Grant/Funding Number",
                            "SecondaryIdDomain": "National Cancer Center, Korea"
                        },
                        {
                            "SecondaryId": "1210520",
                            "SecondaryIdType": "Other Grant/Funding Number",
                            "SecondaryIdDomain": "National Cancer Center, Korea"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "National Cancer Center, Korea",
                    "OrgClass": "OTHER_GOV"
                },
                "BriefTitle": "The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding",
                "OfficialTitle": "Effect of Proton Pump Inhibitor on Prevention of Tumor Bleeding in Patients Under Palliative Chemotherapy for Unresectable Gastric Cancer: a Randomized, Double Blind, and Placebo Controlled Multicenter Trial"
            },
            "StatusModule": {
                "StatusVerifiedDate": "April 2018",
                "OverallStatus": "Terminated",
                "WhyStopped": "Low enroll rate",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "June 2009"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "April 2015",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "May 2017",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "May 26, 2014",
                "StudyFirstSubmitQCDate": "May 26, 2014",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "May 29, 2014",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "April 2, 2018",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "April 4, 2018",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Principal Investigator",
                    "ResponsiblePartyInvestigatorFullName": "Il Ju Choi",
                    "ResponsiblePartyInvestigatorTitle": "Head of Gastric Cancer Cencer",
                    "ResponsiblePartyInvestigatorAffiliation": "National Cancer Center, Korea"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "National Cancer Center, Korea",
                    "LeadSponsorClass": "OTHER_GOV"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "Pusan National University Hospital",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "Kosin University Gospel Hospital",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "Gyeongsang National University Hospital",
                            "CollaboratorClass": "OTHER"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "Yes"
            },
            "DescriptionModule": {
                "BriefSummary": "The aim of this study is the effect of proton pump inhibitor (PPI) with respect to gastric cancer bleeding in inoperable patients.",
                "DetailedDescription": "Tumor bleeding frequently occurs in inoperable gastric cancer patients. Inoperable gastric cancer usually has a large ulcer with friable tumor vessels. Acidic environment in stomach prevents adequate function of coagulation cascade and decrease clot stability. Gastric cancer bleeding may cause significant morbidity and often delays scheduled chemotherapy. National Center Center data showed that about 30% of gastric cancer patient undergoing palliative chemotherapy eventually experience significant cancer bleeding during the treatment period. Once bleeding occurs, endoscopic management is more difficult in gastric cancer patients than in patients with benign peptic ulcers, because the malignant ulcer bed has significant fibrosis. Consequently, gastric cancer patient has a high risk of rebleeding.\n\nProton pump inhibitor (PPI, lansoprazole for example) decrease gastric acid secretion by inhibiting H+,K+-ATPase, and subsequently stabilize blood clot. PPIs are commonly used for benign peptic ulcer or reflux esophagitis, and PPI can decrease recurrent benign ulcer bleeding or other ulcer complications. Moreover, it was reported to prevent bleeding from NSAID or aspirin induced gastric ulcer. Because PPIs are very safe, and they are even available as over-the-counter drugs in some countries. Furthermore, the drug has no interaction with major chemotherapeutic agents commonly used for gastric cancer. Moreover, the drugs are prescribed to the gastric cancer patients when tumor bleeding occurs. Although gastric cancer bleeding is not uncommon and clinically challenging problem, there has been no recommended measure to prevent cancer bleeding. Also there has been no report about the efficacy of PPIs on the gastric cancer bleeding prevention up to now."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Gastric Cancer",
                        "Bleeding"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Gastric cancer bleeding",
                        "Proton pump inhibitor"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Phase 3"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "Randomized",
                    "DesignInterventionModel": "Parallel Assignment",
                    "DesignPrimaryPurpose": "Prevention",
                    "DesignMaskingInfo": {
                        "DesignMasking": "Triple",
                        "DesignWhoMaskedList": {
                            "DesignWhoMasked": [
                                "Participant",
                                "Care Provider",
                                "Investigator"
                            ]
                        }
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "394",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Intervention group",
                            "ArmGroupType": "Active Comparator",
                            "ArmGroupDescription": "Proton pump inhibitor (lansoprazole) therapy for the prevention of gastric cancer bleeding",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Drug: Proton pump inhibitor"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "Placebo group",
                            "ArmGroupType": "Placebo Comparator",
                            "ArmGroupDescription": "Placebo for the prevention of gastric cancer bleeding",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Drug: Placebo"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Drug",
                            "InterventionName": "Proton pump inhibitor",
                            "InterventionDescription": "Lansoprazole 30 mg, daily",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Intervention group"
                                ]
                            },
                            "InterventionOtherNameList": {
                                "InterventionOtherName": [
                                    "Lansoprazole"
                                ]
                            }
                        },
                        {
                            "InterventionType": "Drug",
                            "InterventionName": "Placebo",
                            "InterventionDescription": "Placebo, daily",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Placebo group"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Time-to-bleeding event",
                            "PrimaryOutcomeDescription": "Evaluation of the effect of PPI on the prevention of gastric cancer bleeding",
                            "PrimaryOutcomeTimeFrame": "Up to 6 years of study period"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Transfusion requirement (packed RBC unit)",
                            "SecondaryOutcomeDescription": "Unit of packed RBC required at the time of tumor bleeding",
                            "SecondaryOutcomeTimeFrame": "Up to 6 years of study period"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Number of endoscopy to evaluate tumor bleeding",
                            "SecondaryOutcomeDescription": "No of endoscopic session to evaluation bleeding from advanced gastric cancer",
                            "SecondaryOutcomeTimeFrame": "Up to 6 years of study period"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Number of endoscopic treatment for cancer bleeding",
                            "SecondaryOutcomeDescription": "Total number of endoscopic treatment perfomed for gastric cancer bleeding in each patient",
                            "SecondaryOutcomeTimeFrame": "Up to 6 years of study period"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Overall survival",
                            "SecondaryOutcomeTimeFrame": "Up to 6 years of study period"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nHistologically proven primary gastric adenocarcinoma\nAge \u226518 years\nPlan for 1st line or 2nd line palliative chemotherapy\nCancer staging: metastatic (TxNxM1) or locally advanced unresectable gastric cancer (T4NxMx with unresectable), or T2-3NxMx with inoperable condition\nPerformance status (PS) of 0 to 2 on Eastern Cooperative Oncology Group (ECOG) scale\nAdequate organ functions defined as indicated below: (a) WBC > 3000/mm3, (b) Hb 9.0 g/dL regardless of any transfusion history, (c) Platelet \u2265100,000/mm3, (d) AST/ALT \u2264 2.5 x UNL (\u2264 5 x UNL if liver metastases are present) (e) Total bilirubin \u22641.5x UNL (f) Cr \u22641.5 x UNL\nWritten informed consent\n\nExclusion Criteria:\n\nOther malignancy within the past 3 years except adequately treated non-melanomatous skin cancer or carcinoma in situ of the cervix\nPatients with significant or uncontrolled gastrointestinal bleeding in the past two weeks without evidence of resolution documented by endoscopy or colonoscopy\nPrevious subtotal gastrectomy or total gastrectomy\nPatient with a plan for neo-adjuvant chemotherapy\nLack of physical integrity of the upper gastrointestinal tract or malabsorption syndrome, or inability to take oral medication\nAllergy history to proton pump inhibitor\nSerious concurrent infection or nonmalignant illness that is uncontrolled or whose control may be jeopardized by complications of study therapy\nInadequate cardiovascular function: (a) New York Heart Association class III or IV heart disease, (b) Unstable angina or myocardial infarction within the past 6 months, (c) History of significant ventricular arrhythmia requiring medication with antiarrhythmics or significant conduction system abnormality\nRequirement for therapeutic anticoagulant therapy, aspirin or non-steroidal anti-inflammatory agents except COX-2 selective inhibitor\nRequirement for therapeutic corticosteroid; the use of dexamethasone as anti-emetics or a premedication of chemotherapy-associated hypersensitivity is not an exclusion criteria\nNeed for PPI maintenance treatment for uncontrolled reflux esophagitis or active peptic ulcer\nPsychiatric disorder that would preclude compliance\nPregnant or breast-feeding women\nUntreated folate or vitamine B12 deficiency anemia\nBone marrow metastasis, or evidence of microangiopathic hemolytic anemia (MAHA)",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "MinimumAge": "18 Years",
                "MaximumAge": "90 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Il Ju Choi, M.D., Ph.D.",
                            "OverallOfficialAffiliation": "National Cancer Center, Korea",
                            "OverallOfficialRole": "Principal Investigator"
                        },
                        {
                            "OverallOfficialName": "Gwang Ha Kim, M.D., Ph.D.",
                            "OverallOfficialAffiliation": "Pusan National University Hospital",
                            "OverallOfficialRole": "Principal Investigator"
                        },
                        {
                            "OverallOfficialName": "Moo In Park, M.D., Ph.D.",
                            "OverallOfficialAffiliation": "Kosin University Gospel Hospital",
                            "OverallOfficialRole": "Principal Investigator"
                        },
                        {
                            "OverallOfficialName": "Won Sup Lee, M.D., Ph.D.",
                            "OverallOfficialAffiliation": "Gyeongsang National University Hospital",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Kosin University Gospel Hospital",
                            "LocationCity": "Busan",
                            "LocationZip": "602-702",
                            "LocationCountry": "Korea, Republic of"
                        },
                        {
                            "LocationFacility": "Pusan National University Hospital",
                            "LocationCity": "Busan",
                            "LocationZip": "620-739",
                            "LocationCountry": "Korea, Republic of"
                        },
                        {
                            "LocationFacility": "National Cancer Center",
                            "LocationCity": "Goyang",
                            "LocationZip": "410-769",
                            "LocationCountry": "Korea, Republic of"
                        },
                        {
                            "LocationFacility": "Gyeong Sang National University Hospital",
                            "LocationCity": "Jinju",
                            "LocationZip": "660-702",
                            "LocationCountry": "Korea, Republic of"
                        }
                    ]
                }
            },
            "ReferencesModule": {
                "ReferenceList": {
                    "Reference": [
                        {
                            "ReferencePMID": "28680717",
                            "ReferenceType": "derived",
                            "ReferenceCitation": "Kim YI, Kim MJ, Park SR, Kim HK, Cho SJ, Lee JY, Kim CG, Kim GH, Park MI, Nam BH, Park YI, Choi IJ. Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial. J Gastric Cancer. 2017 Jun;17(2):120-131. doi: 10.5230/jgc.2017.17.e15. Epub 2017 May 31."
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000013274",
                            "ConditionMeshTerm": "Stomach Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000006470",
                            "ConditionMeshTerm": "Hemorrhage"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000005770",
                            "ConditionAncestorTerm": "Gastrointestinal Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000004067",
                            "ConditionAncestorTerm": "Digestive System Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000004066",
                            "ConditionAncestorTerm": "Digestive System Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005767",
                            "ConditionAncestorTerm": "Gastrointestinal Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000013272",
                            "ConditionAncestorTerm": "Stomach Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000010335",
                            "ConditionAncestorTerm": "Pathologic Processes"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M9246",
                            "ConditionBrowseLeafName": "Hemorrhage",
                            "ConditionBrowseLeafAsFound": "Bleeding",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M15754",
                            "ConditionBrowseLeafName": "Stomach Neoplasms",
                            "ConditionBrowseLeafAsFound": "Gastric Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M8576",
                            "ConditionBrowseLeafName": "Gastrointestinal Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M6946",
                            "ConditionBrowseLeafName": "Digestive System Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M6945",
                            "ConditionBrowseLeafName": "Digestive System Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8573",
                            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M15752",
                            "ConditionBrowseLeafName": "Stomach Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "T5486",
                            "ConditionBrowseLeafName": "Stomach Cancer",
                            "ConditionBrowseLeafAsFound": "Gastric Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC23",
                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC06",
                            "ConditionBrowseBranchName": "Digestive System Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "Rare",
                            "ConditionBrowseBranchName": "Rare Diseases"
                        }
                    ]
                }
            },
            "InterventionBrowseModule": {
                "InterventionMeshList": {
                    "InterventionMesh": [
                        {
                            "InterventionMeshId": "D000064747",
                            "InterventionMeshTerm": "Lansoprazole"
                        },
                        {
                            "InterventionMeshId": "D000054328",
                            "InterventionMeshTerm": "Proton Pump Inhibitors"
                        }
                    ]
                },
                "InterventionAncestorList": {
                    "InterventionAncestor": [
                        {
                            "InterventionAncestorId": "D000000897",
                            "InterventionAncestorTerm": "Anti-Ulcer Agents"
                        },
                        {
                            "InterventionAncestorId": "D000005765",
                            "InterventionAncestorTerm": "Gastrointestinal Agents"
                        },
                        {
                            "InterventionAncestorId": "D000004791",
                            "InterventionAncestorTerm": "Enzyme Inhibitors"
                        },
                        {
                            "InterventionAncestorId": "D000045504",
                            "InterventionAncestorTerm": "Molecular Mechanisms of Pharmacological Action"
                        }
                    ]
                },
                "InterventionBrowseLeafList": {
                    "InterventionBrowseLeaf": [
                        {
                            "InterventionBrowseLeafId": "M30069",
                            "InterventionBrowseLeafName": "Lansoprazole",
                            "InterventionBrowseLeafAsFound": "Enhancement",
                            "InterventionBrowseLeafRelevance": "high"
                        },
                        {
                            "InterventionBrowseLeafId": "M30070",
                            "InterventionBrowseLeafName": "Dexlansoprazole",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M27320",
                            "InterventionBrowseLeafName": "Proton Pump Inhibitors",
                            "InterventionBrowseLeafAsFound": "Shaped",
                            "InterventionBrowseLeafRelevance": "high"
                        },
                        {
                            "InterventionBrowseLeafId": "M3878",
                            "InterventionBrowseLeafName": "Antacids",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M3909",
                            "InterventionBrowseLeafName": "Anti-Ulcer Agents",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M8571",
                            "InterventionBrowseLeafName": "Gastrointestinal Agents",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M7641",
                            "InterventionBrowseLeafName": "Enzyme Inhibitors",
                            "InterventionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "InterventionBrowseBranchList": {
                    "InterventionBrowseBranch": [
                        {
                            "InterventionBrowseBranchAbbrev": "Gast",
                            "InterventionBrowseBranchName": "Gastrointestinal Agents"
                        },
                        {
                            "InterventionBrowseBranchAbbrev": "All",
                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                        }
                    ]
                }
            }
        }
    }
}